Catalyst Wire Dossier Catalyst Wire Dossier

Proleukin (interleukin-2)

aldesleukin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Proleukin (interleukin-2), covering 2008-03-04 to 2015-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer [Phase 2]

See pricing